Mercer Global Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
120,171
+36,336
+43% +$405K ﹤0.01% 1679
2026
Q1
$908K Buy
83,835
+24,169
+41% +$207K ﹤0.01% 1618
2025
Q4
$365K Buy
59,666
+41,208
+223% +$246K ﹤0.01% 2083
2025
Q3
$95.6K Buy
+18,458
New +$106K ﹤0.01% 2524
2020
Q4
Sell
-51,885
Closed -$148K 1385
2020
Q3
$148K Buy
+51,885
New +$191K ﹤0.01% 1146
2020
Q2
Sell
-22,871
Closed -$54K 1147
2020
Q1
$54K Buy
22,871
+1,515
+7% +$9.8K ﹤0.01% 1042
2019
Q4
$224K Buy
21,356
+3,614
+20% +$32.7K ﹤0.01% 1037
2019
Q3
$151K Buy
17,742
+464
+3% +$4.55K ﹤0.01% 1049
2019
Q2
$199K Buy
17,278
+1,122
+7% +$14.4K 0.01% 1057
2019
Q1
$227K Buy
+16,156
New +$212K 0.01% 941

Other funds holding PTEN

Mercer Global Advisors's PTEN Position: Q2 2026 in Review

Mercer Global Advisors increased its Patterson-UTI (PTEN) stake by 43% in Q2 2026, buying an estimated $405K and bringing the position to 120,171 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1679.

Mercer Global Advisors first reported a position in PTEN in Q1 2019 and has held it in 10 quarters since. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Mercer Global Advisors held 120,171 shares of Patterson-UTI worth $1.1M as of Q2 2026.
  • Mercer Global Advisors bought 36,336 Patterson-UTI shares in Q2 2026, an estimated $405K.
  • Patterson-UTI made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1679 holding.
  • Mercer Global Advisors first reported a position in Patterson-UTI in Q1 2019 and has held it in 10 quarters since.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.